Table 1.
Correlation between Prdx1 overexpression and clinicopathological parameters of human hilar cholangiocarcinoma
| Parameters | Prdx1 | ||
|---|---|---|---|
|
| |||
| N | N (%) | P | |
| Age | |||
| ≤55 y | 43 | 33 (76.7) | 0.002 |
| >55 y | 45 | 20 (44.4) | |
| Gender | |||
| Male | 62 | 41 (66.1) | 0.081 |
| Female | 26 | 12 (46.2) | |
| Tumor size* | |||
| ≤3 cm | 30 | 16 (53.3) | 0.247 |
| >3 cm | 56 | 37 (66.1) | |
| T stage | |||
| T1-3 | 14 | 2 (14.3) | <0.001 |
| T4 | 74 | 51 (68.9) | |
| N stage | |||
| No | 29 | 11 (37.9) | 0.003 |
| Yes | 59 | 42 (71.2) | |
| Differentiation | |||
| High/moderate | 67 | 37 (55.2) | 0.087 |
| Poor/un-differentiated | 21 | 16 (76.2) | |
| Disease stage | |||
| I/II | 37 | 17 (45.9) | 0.020 |
| III/IV | 51 | 36 (70.6) | |
*
Two cases were unavailable for tumor size.